Active Moderate to Severe Graves' Orbitopathy
1 clinical trials · Condition
◉ Watch Active Moderate to Severe Graves' Orbitopathy
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of SHR-1314 by Subcutaneous Injection in Active Moderate to Severe Graves' Orbitopathy Patients (NCT05394857) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2022-09-13 |
Track Active Moderate to Severe Graves' Orbitopathy automatically
Every clearance here is in the API, with alerts when new ones post.